Clinical Nutrition for Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Type (Oral Nutrition, Parenteral Nutrition, and Enteral Feeding Formulas); By Cancer Type; By Age Group; By Sales Channel, By Region; Segment Forecast, 2024- 2032
- Published Date:May-2024
- Pages: 119
- Format: PDF
- Report ID: PM4926
- Base Year: 2023
- Historical Data: 2019-2022
Report Outlook
Clinical nutrition for cancer care market size was valued at USD 4.62 billion in 2023. The market is anticipated to grow from USD 4.83 billion in 2024 to USD 7.11 billion by 2032, exhibiting the CAGR of 4.9% during the forecast period.
Market Overview
Oncology nutrition has gained a significant popularity over the past decade owing to the growing burden of patients affected by various types of cancer. Moreover, the adoption of nutritional support products in the developing countries is rising owing to the increasing risk of malnutrition among cancer patients. Furthermore, the strong emphasis on the improvement of treatment outcomes for cancer is one of the major factors driving the demand for clinical nutrition for cancer care market. Additionally, the role of nutritional supplements to achieve healthy lifestyle is also contributing to the market expansion.
- For instance, according to the World Health Organization (WHO), healthy lifestyles and less exposure to occupational carcinogens as well as environmental pollution can help to prevent an estimated 30 to 50 percent of all cancer cases.
An increasing awareness related to the potential benefits of nutritional supplements for cancer patients coupled with the growing focus of market players on research & development activities to create evidence for the efficacy of nutritional products are expected to propel the market growth significantly during the forecast timeframe. Moreover, factors such as the increasing need to enhance the immunity of the cancer patient, rising demand for personalized treatment, and the emergence of new and effective nutritional supplements having better treatment outcomes will strengthen the market growth in the projected years.
To Understand More About this Research: Request a Free Sample Report
However, there are various factors that hampers the growth of clinical nutrition for cancer care market. These factors include the expensive prices of premium oncology nutritional supplements, lack of awareness, problems regarding the regulations, differences in cultural practices and dietary habits. Moreover, the failure of the industry players in providing proper clinical evidence to show the effectivity of nutritional support among cancer patients acts as a major restraint for the market growth.
Growth Factors
Growing cancer burden and rising risk of malnutrition in oncology patients are driving the market growth
Cancer is caused when some of the abnormal cells in the body grow in an uncontrolled manner. A considerable increase has been observed in the prevalence of cancer over the past few years owing to numerous risk factors such as sedentary lifestyle, family history, genetic disorders, and environmental exposures. For instance, according to the data published by the American Cancer Society, Inc., in 2022, around 1.9 million new cancer cases were estimated in the U.S. The treatment of cancer often causes appetite loss and can also change the taste of food leading to the high risk of malnutrition. Factors such as the ability to minimize the risk of malnutrition and improve the treatment outcome are increasing the demand for nutritional support products thereby, fostering the growth of clinical nutrition for cancer care market.
Potential benefits of nutrition in cancer treatment will prove beneficial for the market growth
Oncology nutrition is becoming more popular owing to its benefits for the cancer patients. This is a complementary treatment that provides the best results when combined with anti-cancer therapy. A large population pool suffering from cancer focuses on immuno-oncology drugs which suppress the immune system. In such cases, nutritional supplements offer an advantage of modifying the immune system of the patients by providing adequate amount of nutrients. Moreover, the low success rate of cancer treatment owing to the poor nutrition can be eliminated by using nutritional products.
Restraining Factors
Lack of clinical evidence in oncology nutrition limits the expansion of clinical nutrition for cancer care market
Despite the consistent growth of clinical nutrition in cancer care market, there is lack of clinical evidence for the recommended dietary requirements to the cancer patients. This is due to the lack of data related to the assessment of dietary intervention before and during the cancer treatment. Moreover, the public and private organizations are also raising the concern of insufficient clinical evidence owing to which, the demand for oncology nutritional supplements can be hampered.
Report Segmentation
The market is primarily segmented based on type, cancer type, age group, sales channel, and region.
|
By Type |
By Cancer Type |
By Age Group |
By Sales Channel |
By Region |
|
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
By Type Insights
Oral nutrition segment accounted for the largest market share in 2023
The oral nutrition segment held the dominant share of the clinical nutrition for cancer care market in 2023. The large share of this segment is attributed to the ease of consumption of oral supplements and rising number of malnourished cancer patients. Moreover, the oral nutritional supplements provide an advantage to the cancer patients who are experiencing taste disturbances and alterations thereby, improving the quality of life.
By Cancer Type Insights
The lung cancer segment is projected to expand at a significant CAGR over the forecast timeframe
The lung cancer segment is anticipated to register the significant CAGR during the forecast period. Factors such as high prevalence of lung cancer and increasing need of nutritional supplements for this cancer are expected to support the segmental expansion in the projected years. Moreover, the inability to get the nutrients from food coupled with the side effects of lung cancer treatment are the factors that will significantly contribute to the segmental growth in the coming years.
Regional Insights
North America captured the largest share of clinical nutrition for cancer care market
North America held the largest market share in 2023. The large share is primarily attributed to the increasing population pool suffering from different types of cancer. In the U.S., breast, lung, prostate, and colorectal cancers account for the majority portion of all cancer cases. Moreover, the nutritional assessment before designing a treatment protocol of cancer patients in the U.S. is one of the major factors driving the growth of clinical nutrition for cancer care market. Furthermore, the growing number of malnourished cancer patients coupled with rising research & development activities by market players to provide evidence-based recommendations are expected to contribute to the region’s dominance throughout the forecast period.
Asia Pacific region is projected to witness significant growth in the projected years
Asia Pacific region is projected to witness the highest CAGR during the projected period. Factors such as increasing prevalence of cancer and malnourishment among cancer patients, rising demand for early detection and screening, and increasing awareness related to benefits of nutritional supplements among the cancer patients are expected to contribute to the market growth. Moreover, the increasing efforts by market players to create awareness and educate doctors on oncology nutrition as a complementary therapy will fuel the market growth in the upcoming years.
Key Market Players & Competitive Insights
The prominent players account for the majority share of the clinical nutrition for cancer care market
The market is consolidated in nature. Few companies combinedly accounts for the significant market share owing to the factors such as strong product portfolio of nutritional supplements and better direct and indirect presence across the world as compared to other companies. Moreover, the constant focus of key companies towards the launch of new products for various types of cancer patients will strengthen their market shares in the coming years.
Some of the major players operating in the global market include:
- Abbott Nutrition (U.S.)
- Baxter (U.S.)
- Bayer AG (Germany)
- Danone Nutricia (The Netherlands)
- GlaxoSmithKline plc (UK)
- Medtrition, Inc. (U.S.)
- Nestlé Health Science (Switzerland)
- Otsuka Holdings Co., Ltd. (Japan)
- Pfizer Inc. (U.S.)
- Victus, Inc. (U.S.)
Recent Developments in the Industry
- In July 2022, Nestlé Health Science introduced the “Oral Impact Su Yi Su”, the China’s 1st FSMP (Foods for Special Medical Purpose). This product is approved as the dietary supplement to patients suffering from tumour conditions.
Report Coverage
The clinical nutrition for cancer care market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, type, cancer type, age group, sales channel, and their futuristic growth opportunities.
Clinical Nutrition for Cancer Care Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 4.83 billion |
|
Revenue forecast in 2032 |
USD 7.11 billion |
|
CAGR |
4.9% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments covered |
|
|
Regional scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |
FAQ's
key companies in Clinical Nutrition for Cancer Care Market are Nestlé Health Science, Abbott Nutrition, Danone Nutricia
Clinical nutrition for cancer care market exhibiting the CAGR of 4.9% during the forecast period.
The Clinical Nutrition for Cancer Care Market report covering key segments are type, cancer type, age group, sales channel, and region
key driving factors in Clinical Nutrition for Cancer Care Market are Growing cancer burden and rising risk of malnutrition in oncology patients
The global clinical nutrition for cancer care market size is expected to reach USD 7.11 billion by 2032
